[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

United States Opioid Antagonist Drug Market Report 2017

December 2017 | 102 pages | ID: U289F636EBDEN
QYResearch

US$ 3,800.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
In this report, the United States Opioid Antagonist Drug market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:
  • The West
  • Southwest
  • The Middle Atlantic
  • New England
  • The South
  • The Midwest
  • with sales (volume), revenue (value), market share and growth rate of Opioid Antagonist Drug in these regions, from 2012 to 2022 (forecast).
United States Opioid Antagonist Drug market competition by top manufacturers/players, with Opioid Antagonist Drug sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
  • Pfizer
  • Conatus Pharmaceuticals
  • Novartis
  • Intercept Pharmaceuticals
  • Allergan
  • Immuron
  • Takeda
  • Gilead Sciences
  • Genfit
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
  • Tablet
  • Injection
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
  • Hospital
  • Medical Center
If you have any special requirements, please let us know and we will offer you the report as you want.
United States Opioid Antagonist Drug Market Report 2017

1 OPIOID ANTAGONIST DRUG OVERVIEW

1.1 Product Overview and Scope of Opioid Antagonist Drug
1.2 Classification of Opioid Antagonist Drug by Product Category
  1.2.1 United States Opioid Antagonist Drug Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States Opioid Antagonist Drug Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 Tablet
  1.2.4 Injection
1.3 United States Opioid Antagonist Drug Market by Application/End Users
  1.3.1 United States Opioid Antagonist Drug Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 Hospital
  1.3.3 Medical Center
1.4 United States Opioid Antagonist Drug Market by Region
  1.4.1 United States Opioid Antagonist Drug Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West Opioid Antagonist Drug Status and Prospect (2012-2022)
  1.4.3 Southwest Opioid Antagonist Drug Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic Opioid Antagonist Drug Status and Prospect (2012-2022)
  1.4.5 New England Opioid Antagonist Drug Status and Prospect (2012-2022)
  1.4.6 The South Opioid Antagonist Drug Status and Prospect (2012-2022)
  1.4.7 The Midwest Opioid Antagonist Drug Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Opioid Antagonist Drug (2012-2022)
  1.5.1 United States Opioid Antagonist Drug Sales and Growth Rate (2012-2022)
  1.5.2 United States Opioid Antagonist Drug Revenue and Growth Rate (2012-2022)

2 UNITED STATES OPIOID ANTAGONIST DRUG MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Opioid Antagonist Drug Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Opioid Antagonist Drug Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Opioid Antagonist Drug Average Price by Players/Suppliers (2012-2017)
2.4 United States Opioid Antagonist Drug Market Competitive Situation and Trends
  2.4.1 United States Opioid Antagonist Drug Market Concentration Rate
  2.4.2 United States Opioid Antagonist Drug Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Opioid Antagonist Drug Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES OPIOID ANTAGONIST DRUG SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States Opioid Antagonist Drug Sales and Market Share by Region (2012-2017)
3.2 United States Opioid Antagonist Drug Revenue and Market Share by Region (2012-2017)
3.3 United States Opioid Antagonist Drug Price by Region (2012-2017)

4 UNITED STATES OPIOID ANTAGONIST DRUG SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States Opioid Antagonist Drug Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Opioid Antagonist Drug Revenue and Market Share by Type (2012-2017)
4.3 United States Opioid Antagonist Drug Price by Type (2012-2017)
4.4 United States Opioid Antagonist Drug Sales Growth Rate by Type (2012-2017)

5 UNITED STATES OPIOID ANTAGONIST DRUG SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Opioid Antagonist Drug Sales and Market Share by Application (2012-2017)
5.2 United States Opioid Antagonist Drug Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES OPIOID ANTAGONIST DRUG PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Pfizer
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Opioid Antagonist Drug Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Pfizer Opioid Antagonist Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Conatus Pharmaceuticals
  6.2.2 Opioid Antagonist Drug Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Conatus Pharmaceuticals Opioid Antagonist Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Novartis
  6.3.2 Opioid Antagonist Drug Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Novartis Opioid Antagonist Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Intercept Pharmaceuticals
  6.4.2 Opioid Antagonist Drug Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Intercept Pharmaceuticals Opioid Antagonist Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Allergan
  6.5.2 Opioid Antagonist Drug Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Allergan Opioid Antagonist Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Immuron
  6.6.2 Opioid Antagonist Drug Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Immuron Opioid Antagonist Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Takeda
  6.7.2 Opioid Antagonist Drug Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Takeda Opioid Antagonist Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Gilead Sciences
  6.8.2 Opioid Antagonist Drug Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Gilead Sciences Opioid Antagonist Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Genfit
  6.9.2 Opioid Antagonist Drug Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Genfit Opioid Antagonist Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview

7 OPIOID ANTAGONIST DRUG MANUFACTURING COST ANALYSIS

7.1 Opioid Antagonist Drug Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Opioid Antagonist Drug

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Opioid Antagonist Drug Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Opioid Antagonist Drug Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES OPIOID ANTAGONIST DRUG MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States Opioid Antagonist Drug Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Opioid Antagonist Drug Sales Volume Forecast by Type (2017-2022)
11.3 United States Opioid Antagonist Drug Sales Volume Forecast by Application (2017-2022)
11.4 United States Opioid Antagonist Drug Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES

Figure Product Picture of Opioid Antagonist Drug
Figure United States Opioid Antagonist Drug Market Size (K Pcs) by Type (2012-2022)
Figure United States Opioid Antagonist Drug Sales Volume Market Share by Type (Product Category) in 2016
Figure Tablet Product Picture
Figure Injection Product Picture
Figure United States Opioid Antagonist Drug Market Size (K Pcs) by Application (2012-2022)
Figure United States Sales Market Share of Opioid Antagonist Drug by Application in 2016
Figure Hospital Examples
Table Key Downstream Customer in Hospital
Figure Medical Center Examples
Table Key Downstream Customer in Medical Center
Figure United States Opioid Antagonist Drug Market Size (Million USD) by Region (2012-2022)
Figure The West Opioid Antagonist Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Opioid Antagonist Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Opioid Antagonist Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Opioid Antagonist Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Opioid Antagonist Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Opioid Antagonist Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Opioid Antagonist Drug Sales (K Pcs) and Growth Rate (2012-2022)
Figure United States Opioid Antagonist Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Opioid Antagonist Drug Market Major Players Product Sales Volume (K Pcs) (2012-2017)
Table United States Opioid Antagonist Drug Sales (K Pcs) of Key Players/Suppliers (2012-2017)
Table United States Opioid Antagonist Drug Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Opioid Antagonist Drug Sales Share by Players/Suppliers
Figure 2017 United States Opioid Antagonist Drug Sales Share by Players/Suppliers
Figure United States Opioid Antagonist Drug Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Opioid Antagonist Drug Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Opioid Antagonist Drug Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Opioid Antagonist Drug Revenue Share by Players/Suppliers
Figure 2017 United States Opioid Antagonist Drug Revenue Share by Players/Suppliers
Table United States Market Opioid Antagonist Drug Average Price (USD/Pcs) of Key Players/Suppliers (2012-2017)
Figure United States Market Opioid Antagonist Drug Average Price (USD/Pcs) of Key Players/Suppliers in 2016
Figure United States Opioid Antagonist Drug Market Share of Top 3 Players/Suppliers
Figure United States Opioid Antagonist Drug Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Opioid Antagonist Drug Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Opioid Antagonist Drug Product Category
Table United States Opioid Antagonist Drug Sales (K Pcs) by Region (2012-2017)
Table United States Opioid Antagonist Drug Sales Share by Region (2012-2017)
Figure United States Opioid Antagonist Drug Sales Share by Region (2012-2017)
Figure United States Opioid Antagonist Drug Sales Market Share by Region in 2016
Table United States Opioid Antagonist Drug Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Opioid Antagonist Drug Revenue Share by Region (2012-2017)
Figure United States Opioid Antagonist Drug Revenue Market Share by Region (2012-2017)
Figure United States Opioid Antagonist Drug Revenue Market Share by Region in 2016
Table United States Opioid Antagonist Drug Price (USD/Pcs) by Region (2012-2017)
Table United States Opioid Antagonist Drug Sales (K Pcs) by Type (2012-2017)
Table United States Opioid Antagonist Drug Sales Share by Type (2012-2017)
Figure United States Opioid Antagonist Drug Sales Share by Type (2012-2017)
Figure United States Opioid Antagonist Drug Sales Market Share by Type in 2016
Table United States Opioid Antagonist Drug Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Opioid Antagonist Drug Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Opioid Antagonist Drug by Type (2012-2017)
Figure Revenue Market Share of Opioid Antagonist Drug by Type in 2016
Table United States Opioid Antagonist Drug Price (USD/Pcs) by Types (2012-2017)
Figure United States Opioid Antagonist Drug Sales Growth Rate by Type (2012-2017)
Table United States Opioid Antagonist Drug Sales (K Pcs) by Application (2012-2017)
Table United States Opioid Antagonist Drug Sales Market Share by Application (2012-2017)
Figure United States Opioid Antagonist Drug Sales Market Share by Application (2012-2017)
Figure United States Opioid Antagonist Drug Sales Market Share by Application in 2016
Table United States Opioid Antagonist Drug Sales Growth Rate by Application (2012-2017)
Figure United States Opioid Antagonist Drug Sales Growth Rate by Application (2012-2017)
Table Pfizer Basic Information List
Table Pfizer Opioid Antagonist Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Pfizer Opioid Antagonist Drug Sales Growth Rate (2012-2017)
Figure Pfizer Opioid Antagonist Drug Sales Market Share in United States (2012-2017)
Figure Pfizer Opioid Antagonist Drug Revenue Market Share in United States (2012-2017)
Table Conatus Pharmaceuticals Basic Information List
Table Conatus Pharmaceuticals Opioid Antagonist Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Conatus Pharmaceuticals Opioid Antagonist Drug Sales Growth Rate (2012-2017)
Figure Conatus Pharmaceuticals Opioid Antagonist Drug Sales Market Share in United States (2012-2017)
Figure Conatus Pharmaceuticals Opioid Antagonist Drug Revenue Market Share in United States (2012-2017)
Table Novartis Basic Information List
Table Novartis Opioid Antagonist Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Novartis Opioid Antagonist Drug Sales Growth Rate (2012-2017)
Figure Novartis Opioid Antagonist Drug Sales Market Share in United States (2012-2017)
Figure Novartis Opioid Antagonist Drug Revenue Market Share in United States (2012-2017)
Table Intercept Pharmaceuticals Basic Information List
Table Intercept Pharmaceuticals Opioid Antagonist Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Intercept Pharmaceuticals Opioid Antagonist Drug Sales Growth Rate (2012-2017)
Figure Intercept Pharmaceuticals Opioid Antagonist Drug Sales Market Share in United States (2012-2017)
Figure Intercept Pharmaceuticals Opioid Antagonist Drug Revenue Market Share in United States (2012-2017)
Table Allergan Basic Information List
Table Allergan Opioid Antagonist Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Allergan Opioid Antagonist Drug Sales Growth Rate (2012-2017)
Figure Allergan Opioid Antagonist Drug Sales Market Share in United States (2012-2017)
Figure Allergan Opioid Antagonist Drug Revenue Market Share in United States (2012-2017)
Table Immuron Basic Information List
Table Immuron Opioid Antagonist Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Immuron Opioid Antagonist Drug Sales Growth Rate (2012-2017)
Figure Immuron Opioid Antagonist Drug Sales Market Share in United States (2012-2017)
Figure Immuron Opioid Antagonist Drug Revenue Market Share in United States (2012-2017)
Table Takeda Basic Information List
Table Takeda Opioid Antagonist Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Takeda Opioid Antagonist Drug Sales Growth Rate (2012-2017)
Figure Takeda Opioid Antagonist Drug Sales Market Share in United States (2012-2017)
Figure Takeda Opioid Antagonist Drug Revenue Market Share in United States (2012-2017)
Table Gilead Sciences Basic Information List
Table Gilead Sciences Opioid Antagonist Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Gilead Sciences Opioid Antagonist Drug Sales Growth Rate (2012-2017)
Figure Gilead Sciences Opioid Antagonist Drug Sales Market Share in United States (2012-2017)
Figure Gilead Sciences Opioid Antagonist Drug Revenue Market Share in United States (2012-2017)
Table Genfit Basic Information List
Table Genfit Opioid Antagonist Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Genfit Opioid Antagonist Drug Sales Growth Rate (2012-2017)
Figure Genfit Opioid Antagonist Drug Sales Market Share in United States (2012-2017)
Figure Genfit Opioid Antagonist Drug Revenue Market Share in United States (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Opioid Antagonist Drug
Figure Manufacturing Process Analysis of Opioid Antagonist Drug
Figure Opioid Antagonist Drug Industrial Chain Analysis
Table Raw Materials Sources of Opioid Antagonist Drug Major Players/Suppliers in 2016
Table Major Buyers of Opioid Antagonist Drug
Table Distributors/Traders List
Figure United States Opioid Antagonist Drug Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure United States Opioid Antagonist Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Opioid Antagonist Drug Price (USD/Pcs) Trend Forecast (2017-2022)
Table United States Opioid Antagonist Drug Sales Volume (K Pcs) Forecast by Type (2017-2022)
Figure United States Opioid Antagonist Drug Sales Volume (K Pcs) Forecast by Type (2017-2022)
Figure United States Opioid Antagonist Drug Sales Volume (K Pcs) Forecast by Type in 2022
Table United States Opioid Antagonist Drug Sales Volume (K Pcs) Forecast by Application (2017-2022)
Figure United States Opioid Antagonist Drug Sales Volume (K Pcs) Forecast by Application (2017-2022)
Figure United States Opioid Antagonist Drug Sales Volume (K Pcs) Forecast by Application in 2022
Table United States Opioid Antagonist Drug Sales Volume (K Pcs) Forecast by Region (2017-2022)
Table United States Opioid Antagonist Drug Sales Volume Share Forecast by Region (2017-2022)
Figure United States Opioid Antagonist Drug Sales Volume Share Forecast by Region (2017-2022)
Figure United States Opioid Antagonist Drug Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

More Publications

Need Help?

Ask a Question

Market Reports

All Categories